8legs: World stroke congress

#1 out of 1

health22h ago

Health Rounds: Experimental drug shows promise for stroke patients who miss the current medical treatment window

Mid-stage trial shows SCP776 may help stroke patients outside the usual treatment window.
The drug works by delivering IGF-1 to activate brain repair pathways.
FDA granted Fast Track designation for SCP776 for acute ischemic strokes.
AI software improves fetal heart defect detection in second-trimester ultrasounds.
AI-assisted results came from BrightHeart technology across multiple centers.
Study suggests AI could reduce global variability in detecting congenital defects.
Researchers published findings in Obstetrics & Gynecology and reported at the World Stroke Congress.
Stroke patients in the trial were treated about 12 hours after onset on average.
The trial saw higher functional independence at 90 days for SCP776 recipients.

Vote 0